Hyperbaric Oxygen Therapy versus placebo for... (2023 study) Skip to main content
RCT Contemporary clinical trials communications 2023

Hyperbaric Oxygen Therapy versus placebo for post-concussion syndrome (HOT-POCS): A randomized, double-blinded controlled pilot study.

Wright B, Guilliod R, Thakur B, Kundig C, Morales J, Tessler J, et al., Contemporary clinical trials communications, 2023

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The researchers describe a planned pilot trial that compares 20 sessions of hyperbaric oxygen with 20 sessions of a placebo gas in adults who still have symptoms after a concussion.

What They Found

This abstract describes the design of a randomized, double-blinded pilot trial of hyperbaric oxygen therapy for post-concussion syndrome, and it reports no results yet. The study plans to enroll 100 adults who still have symptoms 3-12 months after injury. The HBOT group would get 20 sessions of 100% oxygen at 2.0 ATA. The placebo group would get 20 sessions of 10.5% oxygen and 89.5% nitrogen at 2.0 ATA, which mimics the oxygen level of room air. The main outcome is the change in symptoms on the Rivermead Post-concussion Questionnaire. Secondary outcomes are adverse events, quality of life and cognitive function.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The abstract describes only the plan for a pilot study with no results, so it cannot show whether HBOT works or is safe for post-concussion syndrome.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type RCT
Category Neurological
Source Pubmed
PubMed ID 37416626
Year Published 2023
Journal Contemporary clinical trials communications

Cite This Study

Share
Discuss with a qualified healthcare professional. Then: Review Coverage Guide View Recognised Conditions

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology